About
Dr. Amy Kao joined TVM Capital in April 2023. Prior to TVM, Amy focused on building and funding healthtech opportunities at Oxford Science Enterprises. She was previously a management consultant at EY Global, advising transaction strategies for health care & life science corporations. She has experience in venture ideation from Merck KGaA’s Innovation Centre and company creation from her role as Chief of Staff at a Parkinson’s and Dementia digital health start-up. Amy holds a DPhil in Neuroscience from the University of Oxford, and her academic work in the gut-brain axis has been published in Nature’s Translational Psychiatry and other high-impact journals.
Sign up to see Amy Kao, PhD's full profile
Access investment thesis, focus areas, bio, and contact details for Amy Kao, PhD and 22,000+ other VC professionals.